scholarly journals Dynamics of the Large Progenitor Toxin Complex of Clostridium botulinum

2016 ◽  
Vol 09 (01) ◽  
Author(s):  
Yosuke Kondo ◽  
Satoru Miyazaki
Keyword(s):  
Clostridium Botulinum ◽  
Toxin Complex ◽  
Progenitor Toxin

The Structure of the Neurotoxin-associated Protein HA33/A from Clostridium botulinum Suggests a Reoccurring β-Trefoil Fold in the Progenitor Toxin Complex

2005 ◽  
Vol 346 (4) ◽  
pp. 1083-1093 ◽  
Author(s):  
Joseph W. Arndt ◽  
Jenny Gu ◽  
Lukasz Jaroszewski ◽  
Robert Schwarzenbacher ◽  
Michael A. Hanson ◽  
...  
Keyword(s):  
Clostridium Botulinum ◽  
Toxin Complex ◽  
Progenitor Toxin

scholarly journals Molecular Construction of Clostridium botulinum Progenitor Toxin

1975 ◽  
Vol 29 (4) ◽  
pp. 444-447
Author(s):  
Iwao Ohishi ◽  
Genji Sakaguchi
Keyword(s):  
Clostridium Botulinum ◽  
Progenitor Toxin

scholarly journals Botulinum and Tetanus Neurotoxins

2019 ◽  
Vol 88 (1) ◽  
pp. 811-837 ◽  
Author(s):  
Min Dong ◽  
Geoffrey Masuyer ◽  
Pål Stenmark
Keyword(s):  
Motor Neurons ◽  
Host Proteins ◽  
Tetanus Neurotoxin ◽  
Synaptic Vesicle Exocytosis ◽  
Receptor Recognition ◽  
Toxin Complex ◽  
Vesicle Exocytosis ◽  
Botulinum Neurotoxins ◽  
Distinct Features ◽  
Progenitor Toxin

Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) are the most potent toxins known and cause botulism and tetanus, respectively. BoNTs are also widely utilized as therapeutic toxins. They contain three functional domains responsible for receptor-binding, membrane translocation, and proteolytic cleavage of host proteins required for synaptic vesicle exocytosis. These toxins also have distinct features: BoNTs exist within a progenitor toxin complex (PTC), which protects the toxin and facilitates its absorption in the gastrointestinal tract, whereas TeNT is uniquely transported retrogradely within motor neurons. Our increasing knowledge of these toxins has allowed the development of engineered toxins for medical uses. The discovery of new BoNTs and BoNT-like proteins provides additional tools to understand the evolution of the toxins and to engineer toxin-based therapeutics. This review summarizes the progress on our understanding of BoNTs and TeNT, focusing on the PTC, receptor recognition, new BoNT-like toxins, and therapeutic toxin engineering.

scholarly journals Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System

2014 ◽  
Vol 80 (23) ◽  
pp. 7415-7422 ◽  
Author(s):  
Marite Bradshaw ◽  
William H. Tepp ◽  
Regina C. M. Whitemarsh ◽  
Sabine Pellett ◽  
Eric A. Johnson
Keyword(s):  
Clostridium Botulinum ◽  
Botulinum Neurotoxin ◽  
Expression System ◽  
Single Amino Acid ◽  
Content Type ◽  
Expression Host ◽  
Toxin Complex ◽  
Human Neuronal Cells

ABSTRACTClostridium botulinumsubtype A4 neurotoxin (BoNT/A4) is naturally expressed in the dual-toxin-producingC. botulinumstrain 657Ba at 100× lower titers than BoNT/B. In this study, we describe purification of recombinant BoNT/A4 (rBoNT/A4) expressed in a nonsporulating and nontoxigenicC. botulinumexpression host strain. The rBoNT/A4 copurified with nontoxic toxin complex components provided intransby the expression host and was proteolytically cleaved to the active dichain form. Activity of the recombinant BoNT/A4 in mice and in human neuronal cells was about 1,000-fold lower than that of BoNT/A1, and the recombinant BoNT/A4 was effectively neutralized by botulism heptavalent antitoxin. A previous report using recombinant truncated BoNT/A4 light chain (LC) expressed inEscherichia colihas indicated reduced stability and activity of BoNT/A4 LC compared to BoNT/A1 LC, which was surmounted by introduction of a single-amino-acid substitution, I264R. In order to determine whether this mutation would also affect the holotoxin activity of BoNT/A4, a recombinant full-length BoNT/A4 carrying this mutation as well as a second mutation predicted to increase solubility (L260F) was produced in the clostridial expression system. Comparative analyses of thein vitro, cellular, andin vivoactivities of rBoNT/A4 and rBoNT/A4-L260F I264R showed 1,000-fold-lower activity than BoNT/A1 in both the mutated and nonmutated BoNT/A4. This indicates that these mutations do not alter the activity of BoNT/A4 holotoxin. In summary, a recombinant BoNT from a dual-toxin-producing strain was expressed and purified in an endogenous clostridial expression system, allowing analysis of this toxin.

The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells

2004 ◽  
Vol 319 (2) ◽  
pp. 327-333 ◽  
Author(s):  
Atsushi Nishikawa ◽  
Nobuo Uotsu ◽  
Hideyuki Arimitsu ◽  
Jae-Chul Lee ◽  
Yutaka Miura ◽  
...  
Keyword(s):  
Clostridium Botulinum ◽  
Botulinum Type ◽  
Type C ◽  
Ht 29 ◽  
Progenitor Toxin

Binding properties of Clostridium botulinum type C progenitor toxin to mucins

2007 ◽  
Vol 1770 (4) ◽  
pp. 551-555 ◽  
Author(s):  
Toshio Nakamura ◽  
Noriko Takada ◽  
Takashi Tonozuka ◽  
Yoshiyuki Sakano ◽  
Keiji Oguma ◽  
...  
Keyword(s):  
Clostridium Botulinum ◽  
Binding Properties ◽  
Botulinum Type ◽  
Type C ◽  
Progenitor Toxin
Sign in / Sign up

Export Citation Format

Share Document